*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C676 - Malignant neoplasm of ureteric orifice - as a primary diagnosis code | C676 - Malignant neoplasm of ureteric orifice - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.69 | |
| Readmission Rate (%) | 24.92 | |
| Unplanned Readmission Rate (%) | 12.23 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 38,011 | ||||
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 98 | ||||
| DRG Share of Total Hospitalizations | 0.12 | ||||
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 20.42 | ||||
| Avg LOS at DRG | 3.83 | ||||
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 4.1 | ||||
| Readmission Rate at DRG | 16.85 | ||||
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 28.13 | ||||
| Unplanned Readmission Rate at DRG | 12.43 | ||||
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 11.46 | ||||
| Total Medicare payments at DRG | $294,947,527 | ||||
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $734,681 | ||||
| Total Medicare payment per Day at DRG | $2,024 | ||||
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $1,828 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,760 | ||||
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $7,497 | ||||
| Total Medicare Charges at DRG | $1,806,102,466 | ||||
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $4,740,256 | ||||
| Avg Charges at DRG | $47,515 | ||||
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $48,370 | ||||
| Mortality Rate at DRG | 0.21 | ||||
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| SNF Discharge Rate at DRG | 11.1 | ||||
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 15.31 | ||||
| Home Discharge Rate at DRG | 70.22 | ||||
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 58.16 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 656: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 8,924 | ||||
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 30 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 6.25 | ||||
| Avg LOS at DRG | 4.45 | ||||
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 5.0 | ||||
| Readmission Rate at DRG | 29.58 | ||||
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Unplanned Readmission Rate at DRG | 18.13 | ||||
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Total Medicare payments at DRG | $64,386,006 | ||||
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $219,660 | ||||
| Total Medicare payment per Day at DRG | $1,621 | ||||
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $1,464 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,215 | ||||
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $7,322 | ||||
| Total Medicare Charges at DRG | $321,090,600 | ||||
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $1,098,082 | ||||
| Avg Charges at DRG | $35,981 | ||||
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $36,603 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| SNF Discharge Rate at DRG | 12.79 | ||||
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Home Discharge Rate at DRG | 45.71 | ||||
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 46.67 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 686: KIDNEY AND URINARY TRACT NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 5,314 |
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 12 |
| DRG Share of Total Hospitalizations | 0.02 |
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 2.5 |
| Avg LOS at DRG | 7.03 |
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 7.33 |
| Readmission Rate at DRG | 28.1 |
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
| Unplanned Readmission Rate at DRG | 18.61 |
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
| Total Medicare payments at DRG | $63,967,895 |
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $160,601 |
| Total Medicare payment per Day at DRG | $1,713 |
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $1,825 |
| Total Medicare payment per Hospitalization at DRG | $12,038 |
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $13,383 |
| Total Medicare Charges at DRG | $305,121,479 |
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $941,273 |
| Avg Charges at DRG | $57,418 |
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $78,439 |
| Mortality Rate at DRG | 11.87 |
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
| SNF Discharge Rate at DRG | 17.03 |
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
| Home Discharge Rate at DRG | 26.74 |
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 668: TRANSURETHRAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 38,011 | ||||
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 143 | ||||
| DRG Share of Total Hospitalizations | 0.12 | ||||
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 13.76 | ||||
| Avg LOS at DRG | 3.83 | ||||
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 4.38 | ||||
| Readmission Rate at DRG | 16.85 | ||||
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 28.37 | ||||
| Unplanned Readmission Rate at DRG | 12.43 | ||||
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 14.89 | ||||
| Total Medicare payments at DRG | $294,947,527 | ||||
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $1,126,384 | ||||
| Total Medicare payment per Day at DRG | $2,024 | ||||
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $1,799 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,760 | ||||
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $7,877 | ||||
| Total Medicare Charges at DRG | $1,806,102,466 | ||||
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $7,265,932 | ||||
| Avg Charges at DRG | $47,515 | ||||
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $50,811 | ||||
| Mortality Rate at DRG | 0.21 | ||||
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| SNF Discharge Rate at DRG | 11.1 | ||||
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 16.78 | ||||
| Home Discharge Rate at DRG | 70.22 | ||||
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 52.45 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 656: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 9,196 | ||||
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 38 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 3.66 | ||||
| Avg LOS at DRG | 2.37 | ||||
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 2.05 | ||||
| Readmission Rate at DRG | 12.59 | ||||
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Unplanned Readmission Rate at DRG | 8.69 | ||||
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Total Medicare payments at DRG | $46,147,767 | ||||
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $161,044 | ||||
| Total Medicare payment per Day at DRG | $2,121 | ||||
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $2,065 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,018 | ||||
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $4,238 | ||||
| Total Medicare Charges at DRG | $317,627,222 | ||||
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $967,917 | ||||
| Avg Charges at DRG | $34,540 | ||||
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $25,472 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| SNF Discharge Rate at DRG | 5.54 | ||||
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Home Discharge Rate at DRG | 82.06 | ||||
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | 78.95 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 686: KIDNEY AND URINARY TRACT NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 30 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 2.89 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 4.9 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $333,400 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $2,268 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $11,113 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $1,527,551 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $50,918 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 28,142 | |||
| Total Hospitalizations with ICD C676 - Malignant neoplasm of ureteric orifice | 16 | |||
| DRG Share of Total Hospitalizations | 0.09 | |||
| % of Total ICD C676 - Malignant neoplasm of ureteric orifice in DRG | 1.54 | |||
| Avg LOS at DRG | 5.88 | |||
| Avg LOS with ICD C676 - Malignant neoplasm of ureteric orifice | 4.38 | |||
| Readmission Rate at DRG | 23.6 | |||
| Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | |||
| Unplanned Readmission Rate at DRG | 15.33 | |||
| Unplanned Readmission Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | |||
| Total Medicare payments at DRG | $317,761,689 | |||
| Total Medicare payments with ICD C676 - Malignant neoplasm of ureteric orifice | $150,814 | |||
| Total Medicare payment per Day at DRG | $1,919 | |||
| Total Medicare payment per Day with ICD C676 - Malignant neoplasm of ureteric orifice | $2,154 | |||
| Total Medicare payment per Hospitalization at DRG | $11,291 | |||
| Total Medicare payment per Hospitalization with ICD C676 - Malignant neoplasm of ureteric orifice | $9,426 | |||
| Total Medicare Charges at DRG | $1,612,718,515 | |||
| Total Medicare Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $776,401 | |||
| Avg Charges at DRG | $57,306 | |||
| Avg Charges with ICD C676 - Malignant neoplasm of ureteric orifice | $48,525 | |||
| Mortality Rate at DRG | 0.56 | |||
| Mortality Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | |||
| SNF Discharge Rate at DRG | 18.42 | |||
| SNF Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA | |||
| Home Discharge Rate at DRG | 50.45 | |||
| Home Discharge Rate with ICD C676 - Malignant neoplasm of ureteric orifice | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 19 |